Sec. 720. Monitoring medication prescribing practices for the treatment of post-traumatic stress disorder
453 words·~2 min read·
/bill/116/s/1790/eah/section-720A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Not later than 180 days after the date of enactment of this Act, the Secretary of Defense shall submit to the Committees on Armed Services of the House of Representatives and the Senate a report on the practices for prescribing medication during the period beginning January 1, 2012, and ending December 31, 2017, that were inconsistent with the post-traumatic stress disorder medication guidelines developed by the Department of Defense and the Veterans Health Administration. The report under this subsection shall include the following: A summary of the practices of the Army, Navy, and the Air Force, for prescribing medication during the period referred to in paragraph
(1)that were inconsistent with the post-traumatic stress disorder medication guidelines developed by the Department of Defense and the Veterans Health Administration. Identification of medical centers serving members of the Armed Forces found to having higher than average incidences of prescribing medication during the period referred to in paragraph
(1)that were inconsistent with the post-traumatic stress disorder guidelines. A plan for such medical centers to reduce the prescribing of medications that are inconsistent with the post-traumatic stress disorder guidelines. A plan for ongoing monitoring of medical centers found to have higher than average incidences of prescribing medication that were inconsistent with the post-traumatic stress disorder guidelines by the Department of Defense and the Veterans Health Administration. Based on the findings of the report under subsection (a), the Secretaries of the Army, the Navy, and the Air Force shall each establish a monitoring program carried out with respect to such branch of the Armed Forces that shall provide as follows: The monitoring program shall provide for the conduct of periodic reviews, beginning October 1, 2019, of medication prescribing practices of its own providers. The monitoring program shall provide for regular reports, beginning October 1, 2020, to the Department of Defense and the Veterans Health Administration, of the results of the periodic reviews pursuant to paragraph
(1)of this subsection. The monitoring program shall establish internal procedures, not later than October 1, 2020, to address practices for prescribing medication that are inconsistent with the post-traumatic stress disorder medication guidelines developed by the Department of Defense and the Veterans Health Administration. Not later than 6 months after the date of enactment of this Act, the Secretary of Defense, acting in conjunction with the Director of the Defense Health Agency, shall submit to the Committees on Armed Services of the House of Representatives and the Senate a report on the implementation and results of the Defense Health Agency’s guidance on opioid prescriptions for pain from minor outpatient procedures in Guidance Report entitled Pain Management and Opioid Safety in the Military Health System
(MHS)(DHA–PI 6025.04, issued on June 8, 2018).